Baidu
map

吸附性血液滤过治疗脓毒症欧洲及亚太专家推荐意见解读

2022-07-21 四川大学华西医院肾脏内科 华西医学

该文将欧洲和亚太地区专家分别于2019年和2021年发表的吸附性血液滤过用于脓毒症治疗的专家推荐意见要点进行对比解读,同时结合四川大学华西医院在脓毒症血液净化的经验从吸附性血液滤过治疗适用人群、实验室

中文标题:

吸附性血液滤过治疗脓毒症欧洲及亚太专家推荐意见解读

发布日期:

2022-07-21

简要介绍:

该文将欧洲和亚太地区专家分别于2019年和2021年发表的吸附性血液滤过用于脓毒症治疗的专家推荐意见要点进行对比解读,同时结合四川大学华西医院在脓毒症血液净化的经验从吸附性血液滤过治疗适用人群、实验室指标、治疗实施关键因素(包括启动时机、抗凝方式选择、停机时机判断等)等方面介绍了吸附性血液滤过治疗核心原则,可为临床治疗决策提供参考与借鉴。 

相关资料下载:
[AttachmentFileName(sort=1, fileName=吸附性血液滤过治疗脓毒症欧洲及亚太专家推荐意见解读.pdf)] GetToolGuiderByIdResponse(projectId=1, id=217451c0025388c4, title=吸附性血液滤过治疗脓毒症欧洲及亚太专家推荐意见解读, enTitle=, guiderFrom=华西医学, authorId=0, author=, summary=该文将欧洲和亚太地区专家分别于2019年和2021年发表的吸附性血液滤过用于脓毒症治疗的专家推荐意见要点进行对比解读,同时结合四川大学华西医院在脓毒症血液净化的经验从吸附性血液滤过治疗适用人群、实验室, cover=https://img.medsci.cn/20220721/1658414649202_1608702.jpg, journalId=0, articlesId=null, associationId=2982, associationName=四川大学华西医院肾脏内科, associationIntro=四川大学华西医院肾脏内科, copyright=0, guiderPublishedTime=Thu Jul 21 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #666666;">该文将欧洲和亚太地区专家分别于2019年和2021年发表的吸附性血液滤过用于脓毒症治疗的专家推荐意见要点进行对比解读,同时结合四川大学华西医院在脓毒症血液净化的经验从吸附性血液滤过治疗适用人群、实验室指标、治疗实施关键因素(包括启动时机、抗凝方式选择、停机时机判断等)等方面介绍了吸附性血液滤过治疗核心原则,可为临床治疗决策提供参考与借鉴。&nbsp;</span></p>, tagList=[TagDto(tagId=1337, tagName=脓毒症), TagDto(tagId=457214, tagName=吸附性血液滤过)], categoryList=[CategoryDto(categoryId=14, categoryName=肾内科, tenant=100), CategoryDto(categoryId=38, categoryName=急重症, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=解读, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4649, appHits=102, showAppHits=0, pcHits=515, showPcHits=4547, likes=2, shares=17, comments=2, approvalStatus=1, publishedTime=Sun Jul 24 21:02:00 CST 2022, publishedTimeString=2022-07-21, pcVisible=1, appVisible=1, editorId=0, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=4, createdBy=null, createdName=dajiong, createdTime=Thu Jul 21 22:43:31 CST 2022, updatedBy=6459136, updatedName=艺玮, updatedTime=Sat Jan 06 09:52:15 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=吸附性血液滤过治疗脓毒症欧洲及亚太专家推荐意见解读.pdf)])
吸附性血液滤过治疗脓毒症欧洲及亚太专家推荐意见解读.pdf
下载请点击:
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1234709, encodeId=8a1f1234e09e6, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b2d1930182, createdName=小路非, createdTime=Mon Jul 25 21:31:53 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234696, encodeId=6a14123469696, content=很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51f53730789, createdName=1355b8fem25暂无昵称, createdTime=Mon Jul 25 20:36:08 CST 2022, time=2022-07-25, status=1, ipAttribution=)]
    2022-07-25 小路非

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1234709, encodeId=8a1f1234e09e6, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b2d1930182, createdName=小路非, createdTime=Mon Jul 25 21:31:53 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234696, encodeId=6a14123469696, content=很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51f53730789, createdName=1355b8fem25暂无昵称, createdTime=Mon Jul 25 20:36:08 CST 2022, time=2022-07-25, status=1, ipAttribution=)]
    2022-07-25 1355b8fem25暂无昵称

    很有用

    0

Baidu
map
Baidu
map
Baidu
map